Hematology NewsFDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemiaAugust 17, 2022Transfusion MedicineRare DiseasesPediatricsAnemia
Hematology NewsMomelotinib hits the mark for deadly bone marrow cancerJune 13, 2022CMLAnemiaMixed Topics
Hematology NewsAnticipation key to tackling perioperative anemiaApril 13, 2022AnemiaBleeding Disorders
Hematology NewsRapper sings about living with sickle cell diseaseApril 8, 2022AnemiaBleeding Disorders
Hematology NewsFDA approves first-ever drug for cold agglutinin diseaseFebruary 7, 2022AnemiaTransfusion Medicine
Hematology NewsVoxelotor for sickle cell anemia now down to 4-year-oldsDecember 20, 2021AnemiaPediatrics
Hematology NewsTelemedicine helps SCD patients survive COVID, but more need accessDecember 16, 2021AnemiaCOVID-19 UpdatesPediatrics
Hematology NewsBeta-thalassemia gene therapy achieves lasting transfusion independenceDecember 11, 2021Gene TherapyTransfusion MedicineAnemia
Hematology NewsPoloxamer 188 disappoints for painful SCD vaso-occlusive episodes, study showsteaserMay 27, 2021Anemia
Hematology NewsFDA approves new treatment option for rare anemiaMay 18, 2021AnemiaThrombosisBleeding Disorders
Hematology NewsCommentary: Functional assessment developed for older adults with sickle cell diseaseApril 26, 2021Anemia
Hematology NewsUnique oral drug candidate designed to overcome sickle cell diseaseApril 16, 2021Anemia
